Expert Interviews

Trujillo CPP Study Review: Conclusion

December 22, 2021

Karen O. Klein, MD, leads a discussion of the Trujillo et al study on the importance of individualizing treatment decisions in girls with CPP, including factors that influence the decision to begin and cease treatment.

Trujillo CPP Study Review: Overview and Baseline Characteristics

December 22, 2021

Karen O. Klein, MD, provides an overview of CPP (central precocious puberty) as well as a review of the study design and baseline characteristics from the Trujillo et al study on the importance of individualizing treatment decisions in girls with CPP.

Challenges to Biosimilar Adoption of Insulin Glargine-yfgn

December 01, 2021

Thomas C. Blevins, MD, ECNU, FACE, FNLA, leads the discussion on potential challenges to the adoption of biosimilars in clinical practice, such as for insulin glargine-yfgn in diabetes management, and discusses the importance of patient and provider education.